机构地区:[1]湖北省钟祥市人民医院肾内科
出 处:《临床肾脏病杂志》2015年第12期729-733,共5页Journal Of Clinical Nephrology
基 金:钟祥市社区人群流行病学代谢综合征并肾损害的调查研究(NO.2013YD36)
摘 要:目的调查钟祥城区单位职工代谢综合征(metabolic syndrome,MS)与慢性肾脏病(chronic kidney disease,CKD)之间的相关性的流行情况。方法选择2012年4月至2015年1月在本院健康体检的钟祥城区固定的102个单位固定人群中抽取的64410名职工,采取分层整群多次随机抽样。对职工行全身体格检查及病史问卷调查(有无吸烟、饮酒史及既往肾脏病史),测量其身高、体质量、腰围、臀围、收缩压(systolic blood pressure,SBP)、舒张压(diastolic blood pressure,DBP),计算体质量指数(body mass index,BMI),并进行血糖、血脂(三酰甘油、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇)、肾功能(血肌酐、血尿酸)、尿常规(尿蛋白、尿隐血)的测定。将MS中各个单独组份[中心型肥胖、血压升高、高空腹血糖(fasting plasma glucose,FPG)、高三酰甘油(triglyceride,TG)、高密度脂蛋白胆固醇(high-density lipoprotein,HDL-C)降低等及代谢异常]纳入CKD相关危险因素的分析中进行多元素Logistic回归分析。结果对64410名有效样本的研究中(应答率为100%),得出钟祥城区职工MS的患病率为12.2%(95%CI:7.6%~9.6%)。CKD患病率为7.4%(CKD有4766例,非CKD有59644例);MS人群中CKD的患病率为9.2%(有978例),与非MS人群的CKD患病率(7.0%)之间差异有统计学意义(P:0.001),HDL-C降低、高FPG、血压升高、中心性肥胖、高尿酸均有统计学差异(P〈0.05),OR值(95%CI)依次为:0.521(0.446~0.645)、3.489(2.829~4.311)、2.137(1.745-2.579)、1.507(1.241~1.832)、1.502(1.125~2.005)。结论MS患者中CKD的患病率比非MS人群CKD的患病率显著要高,MS中血压升高、FPG升高、HDL-C降低、中心性肥胖、高尿酸这些代谢异常组份均属于CKD的独立危险因素。防治这些引起MS�Objective To investigate the correlation between metabolic syndrome (MS) and chronic kidney diseases(CKD) among Unit workers in Zhongxiang city. Methods 64 410 employees from fixed population of 102 fixed units in Zhongxiang city which had physical examination in our hospital during April 2012 to January 2015 were collected using stratified multistage random cluster sampling. All investigation objects were interviewed (with or without smoking, drinking history and history of kidney) and given physical examination, including height, weight, waist circumference, hip circumference, systolic blood pressure (SBP), diastolic blood pressure (DBP), body mass index (BMI), glucose, lipids (TG, HDL-C, LDL-C), kidney function (SCr, UA), urine routine test (urine protein,urine occult blood), etc. Multi-element Logistic Regression analysis was utilized to study the risk factors of CKD by introducing individual components in the MS(central obesity, high blood pressure, high FPG, high TG, lower HDL-C, etc. ). Results 64 410 subjects were enrolled in the study and completed the questionnaires. Approximately 12. 2% (95% CI: 7. 6%-9. 6%) of these subjects have at least one indicator of MS. Approximately 7. 4% (4 766 cases of CKD, 59 644 cases of non- CKD) subjects have faced CKD. There are 978 subjects (7. 4%) faced CKD among MS patients. The difference between the prevalence of CKD in the non-MS patients (7. 0 %) and the prevalence rate of CKD in the MS patients(7. 4%) is statistical significant (P = 0. 001). Low HDL-C, high FPG, high blood pressure, high blood pressure and high uric acid are all statistical significant(P〈0. 05). The value of OR(95%CI) are as follows: 0. 521(0. 645-0. 446), 3. 489 (2. 829-2. 579), 2. 137(1. 745- 4. 311), 1. 507(1. 241-1. 832), 1. 502(1. 125-2. 005). Conclusions The prevalence of CKD in the MS is significantly higher than it in the non-MS. And abnormal metabolic components, such as high blood pressure,
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...